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rospective Evaluation of the Clinical
pplication of the American College of
ardiology Foundation/American Society of
chocardiography Appropriateness Criteria for
ransthoracic Echocardiography
. Parker Ward, MD, FACC, Ibrahim N. Mansour, MD, Nicole Lemieux, MD,
itin Gera, MD, Rupa Mehta, MD, Roberto M. Lang, MD, FACC
e sought to prospectively evaluate the clinical application of the American College of Cardiology
oundation/American Society of Echocardiography Appropriateness Criteria (AC) for transthoracic
chocardiography in a single-center university hospital. Indications for transthoracic echocardiograms
TTE) were prospectively determined for consecutive studies by 2 reviewers and categorized, according
o the AC for TTE, as appropriate (A) or inappropriate (I). The overall level of agreement in characterizing
ppropriateness between reviewers was high (kappa  0.83). Among the 1,553 studies for which a
rimary indication was determined, 89% were covered in the AC for TTE. Of these studies, 89% were A,
nd 11% were I. New important TTE abnormalities were more common on A compared with I studies
40% vs. 17%, p  0.001), and noncardiac specialists more frequently ordered I studies (13% vs. 9%,
 0.04). In conclusion, the AC for TTE encompasses the majority of clinical indications for TTE and
ppears to reasonably stratify TTE ordering. However, revisions will be needed to fully capture and
tratify appropriate clinical practice.t
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auring the last decade, there has been a
dramatic increase in the use of cardio-
vascular diagnostic imaging. Diagnos-
tic imaging services reimbursed under
edicare’s physician fee schedule have grown
ore rapidly than any other type of physician
ervice from 1999 to 2003 (1,2). This increased
se has resulted in increased scrutiny of the
ppropriate use of cardiac imaging services
1,2). In an effort to guide physicians and
eimbursement agencies in determining a ra-
rom the Department of Medicine, Section of Cardiology, Non-
nvasive Imaging Laboratories, University of Chicago, Chicago,
llinois. This study was sponsored by a grant from the American
ociety of Echocardiographyc
anuscript received March 21, 2008; revised manuscript received
uly 11, 2008, accepted July 14, 2008.ional approach to the use of diagnostic imag-
ng in the delivery of high-quality care, the
merican College of Cardiology Foundation
ACCF) in conjunction with imaging subspe-
ialty societies have published Appropriateness
riteria (AC) for selected patient indications
or a variety of imaging modalities (3–5).
Recently, the ACCF/American Society of
chocardiography (ASE) AC for Transthoracic
nd Transesophageal Echocardiography have
een published (3). As with other AC docu-
ents, the authors of these criteria used a stan-
ardized methodology in which they combined
vailable evidence with expert opinion to identify
ommon indications for echocardiographic pro-
edures and to determine their level of appropri-
teness (3–5). These criteria attempt to “identify
ommon scenarios encompassing the majority of
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664linical practice” and caution that the AC
hould not be “considered substitutes for
ound clinical judgment or practice expe-
ience” (3). Inherent in this methodology
s that the application of these criteria will
eed to be tested, both to fully describe
heir application on current clinical prac-
ice and to shed light on their potential
mpact on the delivery of high quality of
edical care. Thus, the purpose of this
tudy was to test the feasibility of pro-
pective clinical application of the pub-
ished AC for transthoracic echocardiog-
aphy and to describe their application to
urrent clinical practice at a single-center
niversity hospital.
ethods
ll patients referred for a complete
ransthoracic echocardiogram (TTE)
o the echocardiography laboratories at
he University of Chicago Medical
enter between July and September
007 were eligible for inclusion. The
rotocol was approved by the Institu-
ional Review Board, and all patients
rovided informed consent. For each
tudy, patient demographic informa-
ion, referring physician specialty, out-
atient versus inpatient status, and the
rimary indication for the study were
rospectively determined and the re-
ults of the TTE recorded.
ndication determination. For each
tudy, written requisitions and hospi-
al/practice records were prospectively
eviewed, and previous echocardio-
raphic testing or other previous rele-
ant imaging testing was recorded. A
rimary indication for each study was
etermined independently by 2 investi-
ators who were blinded to the results
f the echocardiogram. Investigators
ere asked to select an indication num-
er or category for each study from the
ollowing 53 options: any of the indi-
ations for TTE (indication numbers 1
o 51) listed in the AC for echocardi-
graphy, not addressed (NA; i.e., pri-
ary indication determinable but not
ddressed in AC for echocardiogra-
hy), or undetermined (UD; i.e., insuf- gcient data to determine a primary
ndication). A primary consensus indi-
ation for each study was then deter-
ined for all further analysis.
For studies in which the 2 investiga-
ors were in agreement, the indication/
ategory (numbers 1 to 51, NA, or UD)
elected served as the final primary
onsensus indication. For those studies
n which there was not agreement be-
ween the 2 investigators on the indi-
ation number or category (NA or
D), a third investigator indepen-
ently reviewed the data and chose 1 of
he 2 initial selections as a final primary
onsensus indication.
chocardiograms. Complete 2-di-
ensional and color Doppler echocar-
iograms, including pulsed-wave
oppler examination of both mitral
nd pulmonary vein inflows and tissue
oppler imaging for the septal mitral
alve annulus, were performed in all
atients with the use of a full-platform
chocardiographic instrument (Philips
E33, Philips Medical Systems, Ando-
er, Massachusetts). All echocardio-
rams were performed and interpreted
n accordance with the preferred rec-
mmendations of the ASE (6,7), as is
tandard in our laboratory. All studies
ere interpreted by one of 7 expert
chocardiographers, and the findings
hat were used for analysis in this study
epresent those reported on the final
linical echocardiogram report.
As is standard in our laboratory, left
entricular (LV) function was assessed
ith the use of visual or quantitative
ethods, and ASE-recommended def-
nitions for LV dysfunction (left ven-
ricular ejection fraction [LVEF]
54%), moderate LV dysfunction
LVEF 30% to 44%), and severe LV
ysfunction (LVEF 30%) were used
6). The severity of valvular heart dis-
ase was determined with the use of a
ombination of expert visual opinion
nd the preferred quantitative method-
logy and definitions of the ASE (7).
ight ventricular systolic function was
etermined by expert visualization. Re-
ional wall motion abnormalities were getermined by expert opinion and de-
ned as a hypokinesis, akinesis, or dys-
inesis reported in any of the 17 myo-
ardial segments.
The presence of pulmonary hyper-
ension was defined as an estimated
ight ventricular systolic pressure of
35 mm Hg, as determined from the
aximum tricuspid regurgitation ve-
ocity and estimated right atrial pres-
ure. Moderate or greater pulmonary
ypertension was defined as an esti-
ated right ventricular systolic pres-
ure of 50 mm Hg. Diastolic dys-
unction was determined based on
xpert review of mitral, pulmonary,
nd tissue Doppler data and is re-
orted as mild (impaired relaxation,
rade I), moderate (impaired relax-
tion with moderately elevated filling
ressures or “pseudonormal,” grade
I), or severe (impaired relaxation
ith marked elevation of filling pres-
ures, grade III or IV).
lassiﬁcation of TTE ﬁndings. A compos-
te end point of “any TTE abnormality”
as defined as LV dysfunction (LVEF
54%); aortic stenosis (aortic valve
rea 1.5 cm2); a regional wall motion
bnormality; right ventricular dysfunc-
ion; any pulmonary hypertension; mild
r greater mitral, aortic, or tricuspid
egurgitation; diastolic dysfunction; or
ther significant abnormality (mitral
tenosis [mitral valve area 1.5 cm2],
oderate or greater pulmonary valve
egurgitation, moderate or greater peri-
ardial effusion, or any other significant
bnormality, i.e., thrombus, vegetation,
umor).
A “major TTE abnormality” was de-
ned as moderate or greater LV dys-
unction (LVEF 45%); moderate or
reater mitral, aortic, or tricuspid re-
urgitation; aortic stenosis (aortic valve
rea 1.5 cm2); a regional wall motion
bnormality; right ventricular dysfunc-
ion; moderate or greater pulmonary
ypertension; moderate or severe dia-
tolic dysfunction; or other significant
bnormality (mitral stenosis [mitral
alve area 1.5 cm2]); moderate or
reater pulmonary valve regurgitation;
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665oderate or greater pericardial effu-
ion; any other significant abnormality
i.e., thrombus, vegetation, tumor).
Studies for which a previous TTE
tudy had been performed were com-
ared with the previous study. A “new
TE abnormality” and a “new major
TE abnormality” were defined re-
pectively as “any TTE abnormality” or
any major TTE abnormality” that was
ot previously known or in which there
ad been a change of at least one
everity grade from a previous TTE
i.e., previously mild LV dysfunction,
ow moderate LV dysfunction).
tatistical analysis. Comparisons be-
ween study and patient characteristics,
chocardiographic findings, and levels of
ppropriateness were performed with
hi-square tests or Fisher exact tests for
ategorical data as appropriate, and Stu-
ent t test for continuous data with the
se of a 2-tailed p value0.05 for statis-
ical significance. Interobserver variability
n the determination of indication/
ategory and level of appropriateness is
xpressed as percent agreement between
independent reviewers and with the use
f kappa statistics. For indication/
ategory determination, interobserver
omparisons represent the frequency in
hich the reviewers agreed on the indi-
ation number or category (i.e., indica-
ion numbers 1 to 51, NA, or UD). For
evel of appropriateness determination,
nterobserver comparisons represent the
requency in which reviewers selected
ndications with a matching level of ap-
ropriateness (A vs. I), although not nec-
ssarily an identical indication number.
tudies for which both reviewers chose
D or NA (thus, no appropriateness
evel was available for either reviewer
election) were excluded from appropri-
teness level comparisons.
esults
verall, 1,580 echocardiographic stud-
es performed on 1,431 patients en-
olled in the study, with 52% (n 814)
eing outpatient studies and 48% (n 
66) being inpatient studies. The mean tatient age for all studies was 58.8 
6.9 years, and 53% (n  837) of the
tudies were performed on women.
ompared with patients who received
nly one study (n  1,314) in the
-month enrollment period, those who
eceived more than one study (n 117)
ere not significantly different in age
57.4  16.9 years vs. 59.0  17 years,
 0.32) or gender (50% vs. 53%
omen, p  0.53). When previously
nrolled patients (n  149) underwent
uplicate studies, they were signifi-
antly more likely to be inpatients com-
ared with those patients undergoing
rst-time studies (74% vs. 46%, p 
.001). Cardiac specialists (48%; de-
ned as cardiologists [44%] or cardiac
urgeons [4%]) were the most common
eferring specialty. The other referring
pecialties included internal medicine
hysicians (36%), noncardiac surgical
pecialties (8%), neurology (4%), anes-
hesiology (2%), and other (2%).
Of the 1,580 studies included, a
rimary consensus indication could not
e determined (UD) in 1.7% (n  27).
f the remaining 1,553 studies, 89.2%
n  1,385) were ordered for indica-
ions outlined in the AC for echocar-
iography (indication numbers 1 to
1), whereas 10.8% (n  168) were
ot. The frequency of studies ordered
or the most common 10 indications as
utlined in the AC document is sum-
arized in Table 1. Overall, the most
ommon indication for obtaining a
TE study was indication number 1
“symptoms potentially due to sus-
ected cardiac etiology. . .”). Of the
,385 studies for which the AC docu-
ent could be applied, 88.7% (n 
,228) were ordered for appropriate (A)
ndications, whereas 11.3% (n  157)
ere ordered for inappropriate (I) indi-
ations. The patient and study charac-
eristics according to level of appropri-
teness are listed in Table 2. Compared
ith A studies, I studies were signifi-
antly more likely to be ordered on
ounger patients (55.9  18.7 years vs.
9.9  16.7 years, p  0.005), outpa-
ients (78% of I studies vs. 45% of A mtudies, p  0.001), and those with a
revious TTE (57% of I studies vs. 31%
f A studies, p  0.001). It was found
hat I studies were less likely to be
rdered by cardiac specialists compared
ith A studies (42% of I studies vs.
1% of A studies, p  0.04), and they
ere more likely to be ordered by in-
ernal medicine physicians compared
ith A studies (47% of I studies vs.
7% of A studies, p  0.02). Overall,
oncardiac specialists ordered a greater
requency of I studies than cardiac spe-
ialists (13% vs. 9%, p  0.04).
Transthoracic echocardiogram find-
ngs according to level of appropriate-
ess are listed in Table 3. Overall, a
TE abnormality was found in 68% of
tudies, including 31% with LV dys-
unction. Of the studies with an abnor-
al TTE finding, 29% were un-
hanged from previous TTE, leaving a
otal of 48% of all studies with a new
TE abnormality. The frequency of
ny abnormal TTE finding was similar
hen comparing A and I studies (70%
s. 65%, p  0.23). However, new
chocardiographic abnormalities were
ignificantly more common on A com-
ared with I studies (52% vs. 29%, p 
.001). A major TTE abnormality was
ound on 54% of all studies, including
1% with moderate or greater LV dys-
unction. Major TTE abnormalities
ere present with similar frequency
mong A and I studies (56% vs. 52%, p
0.30), although new major TTE
bnormalities were significantly more
ommon among A compared with I
tudies (40% vs. 17%, p  0.001).
An analysis of the individual I indi-
ations is summarized in Table 4. The
ost common I indication was indica-
ion number 42 (“Routine [yearly] re-
valuation of patients with heart failure
systolic or diastolic] in which there
as no change in clinical status.”). The
indication for which the most new
ajor TTE abnormalities were identi-
ed was indication 21 (“Routine
yearly] re-evaluation of an asymptom-
tic patient with mild native AS or
ild-moderate native MS and no
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666hange in clinical status”). Indication
2 (68% by cardiac specialists vs. 32%
y noncardiac specialists) and indica-
ion 21 (61% by cardiac specialists vs.
9% by noncardiac specialists) were
lso the only I indications more likely
o be ordered by cardiac compared with
oncardiac specialists.
On review of individual studies or-
ered for indication number 42, 29%
Table 1. The 10 Most Common Indications Listed
Indication as
Number 1: Symptoms potentially caused by suspec
lightheadedness, syncope, TIA, cerebrovascular e
Number 2: Previous testing that is concerning for h
ECG, elevation of serum BNP)
Number 43: Re-evaluation of a patient with known
in clinical status
Number 10: Evaluation of known or suspected pulm
estimated pulmonary artery pressure
Number 17: Initial evaluation of murmur in patient
disease
Number 31: Initial evaluation of suspected infective
new murmur
Number 11: Evaluation of hypotension or hemodyn
Number 36: Evaluation of pericardial conditions inc
effusive-constrictive conditions, patients post-car
Number 41: Initial evaluation of known or suspecte
status
Number 42: Routine (yearly) re-evaluation of patien
clinical status
Results are reported as the percentage of all studies for wh
AC  Appropriateness Criteria; BNP  brain natriuretic pe
Table 2. Study and Physician Referral Characteri
Appropriateness as Outlined in the AC for Echoc
All St
(n 
Age, yrs 58.8 
Women, % 5
Outpatients, % 5
Previous TTE, % 3
Ordering physician specialty, %
Cardiac specialists‡ 4
Internal medicine specialties 3
Surgery (noncardiac)
Other
*p  0.01 compared with AC studies. †p  0.001 compared
AC  Appropriatness Criteria; NA  studies with indications noere ordered as a follow-up of a previ-
us TTE, with a recorded LVEF on
he previous study of 35%, to assess a
atient’s candidacy for implantable de-
brillator placement after a trial of
aximal medical therapy or a coronary
evascularization. This clinical setting
as not specifically addressed in the
C document, yet reviewers consis-
ently placed these studies under indi-
the AC for Echocardiography for Which TTE Were
ted in the AC for Echocardiography
cardiac etiology, including but not limited to dyspne
ts
disease (i.e., chest X-ray, baseline scout images for s
rt failure (systolic or diastolic) to guide therapy in a
ary hypertension including evaluation of right ventric
whom there is a reasonable suspicion of valvular or
ocarditis (native and/or prosthetic valve) with positi
c instability of uncertain or suspected cardiac etiolog
ng but not limited to pericardial mass, effusion, cons
surgery, or suspected pericardial tamponade
art failure (systolic or diastolic) in whom there is no
ith heart failure (systolic or diastolic) in whom there
r which indication is covered in the AC for Echocardiography
; ECG  electrocardiogram; TIA  transient ischemic attack.
s for All Studies for Which a Primary Indication C
iography
s
3)
Appropriate Indication
(n  1,228)
.9 59.9  16.7
54
45
31
51
37
4
8
h AC studies. ‡Includes cardiologists and cardiac surgeons. §p
t addressed in the Appropriateness Criteria for Echocardiography;ation 42 based on clinical information
onsistent with this indication as writ-
en. Among studies ordered for Indica-
ion 21, 72% were ordered to follow up
he documentation of previously mild
ortic stenosis.
The indications for which TTE
tudies were ordered that are not
ddressed in the AC document are
isted in Table 5. The most common
dered in an Academic Institution
Percent of All Studies for
Which the Indication
Was Covered in the AC
for Echocardiography
(n  1,385)
ortness of breath, 28% (n 384)
s echocardiogram, 9% (n 122)
nt with a change 6% (n 81)
function and 5% (n 70)
ctural heart 5% (n 62)
lood cultures or a 4% (n 54)
3% (n 45)
ive pericarditis, 3% (n 39)
nge in clinical 3% (n 38)
o change in 3% (n 37)
Be Determined, According to Level of
ppropriate Indication
(n  157)
NA Studies
(n  168)
55.9  18.7* 53.5  15.6†
55 48
78† 72†
57† 49†
42§ 35†
47§ 20†
6 41†
5 4§
.05 compared with AC studies.in Or
Lis
ted a, sh
ven
eart tres
hea patie
on ular
s for stru
end ve b
ami y
ludi trict
diac
d he cha
ts w is n
ich fo .stic ould
ard
udie
1,55
Ina
16
3
1
6
8
6
8
8
wit  0
TTE  transthoracic echocardiogram.
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667ndication was pre-operative evalua-
ion, accounting for 50% of all NA
tudies, with 27% before solid organ
ransplant and 20% before general
oncardiac surgery. Indications re-
ated to heart failure or native or
rosthetic valvular disease for which
he severity or frequency of follow-up
s not addressed in the AC document
ccounted for 30%. Overall, 43% of
tudies with indications not addressed
ere related to solid organ transplant
rograms at our institution.
Our analysis of the interobserver
ariability for indication determination
evealed that the 2 initial independent
eviewers had 84% agreement (kappa
.82) on the determination of indica-
ion/category (indication numbers 1 to
1, NA, or UD) and 97% agreement
kappa  0.83) when selecting indica-
ions with the same level of appropri-
Table 3. Transthoracic Echocardiogram Findings
Appropriateness as Outlined in the AC for Echoc
TTE Findings
LV dysfunction (LVEF 54%), %
 Moderate LV dysfunction (LVEF 45), %
RV dysfunction, %
Regional wall motion abnormality, %
Aortic stenosis (AVA 1.5 cm2), %
 Mild AR, %
 Moderate AR, %
 Mild MR, %
 Moderate MR, %
 Mild TR, %
 Moderate TR, %
Pulmonary HTN (RVSP 35 mm Hg), %
 Moderate pulmonary HTN (RVSP 50 mm Hg), %
Diastolic dysfunction, %
 Moderate diastolic dysfunction, %
Other signiﬁcant ﬁnding§, %
Any TTE abnormality, %
New TTE abnormality, %
Major TTE abnormality, %
New major TTE abnormality, %
*p  0.05 compared with AC studies. †p  0.01 compared
cm2,  moderate pericardial effusion, thrombus, vegetation
AR  aortic regurgitation; AVA  aortic valve area; HTN 
RV  right ventricular; RVSP  right ventricular systolic preteness (A or I). tiscussion
n this study, we found that the AC for
chocardiography encompasses the ma-
ority of indications for TTE that are
rdered in routine clinical practice at a
ingle-center university hospital and
hat a large majority of the studies
rdered for indications addressed in the
C document are found to be A. The
C for echocardiography also appear
o reasonably stratify TTE test order-
ng because A studies were found to
ave significantly more newly recog-
ized echocardiogram abnormalities
han I studies. There remain a small
umber of studies (11%) in our clin-
cal practice that are not addressed by
he AC for echocardiography, which
uggests that additional study and
evisions of this document will be
ecessary to fully encompass and
tratify the appropriate clinical prac-
All Studies for Which a Primary Indication Could
iography
All Studies
(n  1,553)
Appropriate Studies
(n  1,228)
31 (n 486) 32 (n 393)
21 (n 324) 22 (n 266)
23 (n 361) 25 (n 311)
13 (n 207) 14 (n 167)
5 (n 82) 5 (n 63)
11 (n 166) 11 (n 129)
3 (n 51) 3 (n 39)
23 (n 356) 24 (n 299)
9 (n 147) 10 (n 125)
26 (n 405) 29 (n 351)
12 (n 187) 14 (n 167)
22 (n 338) 24 (n 298)
11 (n 176) 13 (n 157)
27 (n 424) 28 (n 344)
12 (n 191) 13 (162)
7 (n 101) 7 (n 84)
68 (n 1,055) 70 (n 855)
48 (n 745) 52 (n 643)
54 (n 838) 56 (n 687)
35 (n 550) 40 (n 488)
AC studies. ‡p  0.001 compared with AC studies. §Includes
or).
ertension; LV  left ventricular; LVEF  left ventricular ejectio
; TR  tricuspid regurgitation; other abbreviations as in Tableice of echocardiography. iThis study represents the first pub-
ished prospective study of the clinical
pplication of any of the AC docu-
ents and the first study of any kind to
valuate the clinical application of AC
or echocardiography. We used pro-
pective methodology in an attempt to
dentify the “true” indication of the
tudy. Using this approach, we found
hat it was possible to identify a pri-
ary indication for the vast majority of
linically ordered studies. The small
raction (2%) for which a primary indi-
ation could not be determined were
rimarily related to the inability to
ccess the most recent medical records.
e also found that although there was
ood agreement between independent
eviewers in assigning a primary indi-
ation (84%), for a number of studies,
ore than one indication was sup-
orted by the clinical data. This finding
Determined, According to Level of
Inappropriate Studies
(n  157)
NA Studies
(n  168)
34 (n 53) 24 (n 40)*
24 (n 38) 12 (n 20)†
17 (n 27)* 14 (n 23)†
15 (n 24) 10 (n 16)
6 (n 9) 6 (n 10)
13 (n 20) 10 (n 17)
4 (n 6) 4 (n 6)
21 (n 33) 14 (n 24)†
8 (n 12) 6 (n 10)
17 (n 26)† 17 (n 28)†
8 (n 12)* 5 (n 8)†
14 (n 22)† 11 (n 18)‡
8 (n 12) 4 (n 7)†
26 (n 41) 23 (n 39)
11 (n 17) 7 (n 12)*
8 (n 12) 3 (n 5)
65 (n 102) 58 (n 98)†
29 (n 45)‡ 34 (n 57)‡
52 (n 81) 42 (n 70)‡
17 (n 27)‡ 21 (n 35)‡
oderate pulmonic regurgitation, mitral stenosis (MVA 1.5
ction; MR  mitral regurgitation; MVA  mitral valve area;for Be
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ssure 2.llustrates the sometimes-subjective
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668ature of indication assignment and
arries potential implications if these
riteria gain widespread use for reim-
ursement determinations. Mitigating
his concern was our finding that re-
iewers demonstrated excellent agree-
ent (97%) in selecting any A versus
ny I indication. Thus, although stud-
es may have more than one reasonable
rimary indication, the consensus on
hether the study is ultimately deemed
or I by the AC for echocardiography
Table 4. Ordering Physician Specialty and TTE Fin
Inappropriate
Indication Number
Number 5: Patients who have isolated APC or PVC
without other evidence of heart disease, %
Number 7: Evaluation of LV function with previous
ventricular function evaluation within the past
year with normal function (such as previous
echocardiogram, LV gram, SPECT, CMR) in
patients in whom there has been no change in
clinical status, %
Number 15: Initial evaluation of patient with
suspected pulmonary embolism to establish
diagnosis, %
Number 19: Routine (yearly) re-evaluation of mitral
valve prolapse in patients with no or mild MR
and no change in clinical status, %
Number 21: Routine (yearly) re-evaluation of an
asymptomatic patient with mild native AS or
mild-moderate native MS and no change in
clinical status, %
Number 25: Routine (yearly) evaluation of native
valvular regurgitation in an asymptomatic
patient with mild regurgitation, no change in
clinical status, and normal LV size, %
Number 29: Routine (yearly) evaluation of a
patient with a prosthetic valve in whom there is
no suspicion of valvular dysfunction and no
change in clinical status, %
Number 32: Evaluation of native and/or prosthetic
valves in patients with transient fever but
without evidence of bacteremia or new
murmur, %
Number 39: Routine evaluation of patients with
systemic hypertension without suspected
hypertensive heart disease, %
Number 40: Re-evaluation of a patient with known
hypertensive heart disease without a change in
clinical status, %
Number 42: Routine (yearly) re-evaluation of
patients with heart failure (systolic or diastolic)
in whom there is no change in clinical status, %
Number 47: Routine (yearly) evaluation of
hypertrophic cardiomyopathy in a patient with
no change in clinical status, %
AS  aortic stenosis; APC  atrial premature contraction; CM
SPECT  single-photon emission computed tomography; ots high. aStudies ordered for indications not
ddressed by the AC document repre-
ented a small but significant fraction
11%) of those ordered at our institu-
ion. Although some were triggered by
rograms specific to a large university
ospital (e.g., solid-organ transplant
rogram), which would be expected to
epresent only a fraction of the broad
linical practice of echocardiography,
thers illustrate gaps in the AC for
chocardiography that will need to be
s for Inappropriate Indications (n  157) in the AC
All Inappropriate
Studies
(n  157)
Percent Ordered
by Cardiac
Specialists
11 (n 17) 29 (n 5)
8 (n 12) 25 (n 3)
4 (n 6) 0 (n 0)
6 (n 9) 33 (n 3)
11 (n 18) 61 (n 11)
6 (n 9) 33 (n 3)
6 (n 9) 44 (n 4)
10 (n 15) 27 (n 4)
2 (n 3) 0 (n 0)
13 (n 20) 40 (n 8)
24 (n 37) 68 (n 25)
1 (n 2) 0 (n 0)
cardiac magnetic resonance; LV gram  left ventriculogram;
abbreviations as in Tables 2 and 3.ddressed for the document to more oompletely encompass the common
linical practice of TTE. For example,
ndications related to preoperative car-
iac evaluation were the most common
roup of indications not addressed.
Since the development of the AC for
chocardiography, revised American
ollege of Cardiology/American Heart
ssociation guidelines for pre-operative
valuation before noncardiac surgery have
een published and include more defin-
tive recommendations on the pre-
Echocardiography
Percent With
New TTE
Abnormalities
Percent With
New Major TTE
Abnormalities
12 (n 2) 6 (n 1)
17 (n 2) 8 (n 1)
83 (n 5) 17 (n 1)
11 (n 1) 11 (n 1)
39 (n 7) 33 (n 6)
22 (n 2) 11 (n 1)
22 (n 2) 22 (n 2)
40 (n 5) 13 (n 2)
0 (n 0) 0 (n 0)
20 (n 4) 15 (n 3)
38 (n 14) 24 (n 9)
50 (n 1) 0 (n 0)
mitral stenosis; PVC  premature ventricular contraction;ding for
R  MS perative assessment of LV function, which
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669s frequently assessed with TTE (8).
hus, revisions of the AC for echocardi-
graphy aimed at incorporating the pre-
perative use of TTE may now be more
easible.
Additionally, a variety of indications
elated to the severity or frequency of
ollow-up of patients with common
onditions such as heart failure or val-
ular heart disease are not addressed in
he AC for echocardiography. These
missions likely relate to the lack of
lear evidence or consensus regarding
he appropriate use of TTE in these
linical settings. It is notable that over-
ll we find that studies ordered for
ndications not addressed in the AC
ocument were significantly less likely
o have a new TTE abnormality or a
ew major TTE abnormality than
tudies deemed to be A by the AC
ocument. Further study with larger
umbers of studies for these indications
ill be needed to establish the level of
ppropriateness of TTE in each of
hese clinical settings.
Studies determined to be I by the
C document were more commonly
rdered on younger patients, outpa-
ients, and those with a previous TTE
Table 5. Indications Not Addressed in the AC fo
Indication
Native valvular stenosis: routine revaluation not ad
moderate AS, previous mild AS, or mild-to-mode
previous evaluation with no change clinical statu
Native valvular regurgitation: routine revaluation no
previous moderate regurgitation, previous mild r
dilated LV, or 1 yr since previous study with n
status), %
Heart failure: revaluation of patient with heart failu
1 yr since previous study with no change in cl
Prosthetic valve: revaluation of a patient with a pro
no clinical change, %
Routine follow-up: after heart transplant, no chang
Pre-operative evaluation
Pre-operative evaluation: noncardiac surgery, %
Pre-operative evaluation: solid-organ transplant, %
Pre-operative evaluation: assess LV or valve functio
bypass surgery, %
Other (miscellaneous), %
Abbreviations as in Tables 2, 3, and 4.tudy. It is not surprising that outpa- nient studies were more likely than
npatient studies to be ordered for I
ndications. The reason for inpatient
tudies is frequently related to new
igns or symptoms, or other changes in
linical status, which all are key clinical
eatures used throughout the AC doc-
ment for differentiating A from I in-
ications. The fact that the recipients
f I studies more commonly had a
revious TTE is also an expected re-
ult, given that a majority of I indica-
ions as written specifically involve fol-
ow up of a previous TTE study (54%)
3). This fact also explains the high rate
f composite TTE abnormalities
mong I studies (65%), because many
ere performed to follow up a known
chocardiogram abnormality. Because
ewer of the A indications involve re-
valuation of a previous TTE study
26%) (3) and, thus, fewer were per-
ormed to follow up known echocar-
iogram abnormalities, it is also not
urprising that we did not find a signif-
cant difference in overall TTE abnor-
alities between A and I studies.
We do find that the AC document
tratifies indications according to the
ikelihood of finding a newly recog-
hocardiography (n  168 Studies)
Indication Not Covere
in the AC Document
(n  168)
sed (i.e., previous
MS 1 yr since
8 (n 14)
dressed (i.e.,
rgitation with
ange clinical
6 (n 11)
ystolic or diastolic)
l status, %
13 (n 21)
tic valve 1 yr, 3 (n 5)
clinical status, % 16 (n 27)
20 (n 34)
27 (n 45)
fore coronary 3 (n 5)
4 (n 6)ized TTE abnormality, because new lTE abnormalities were significantly
ore common in A compared with I
tudies. Because there may be discus-
ion about the clinical significance of
ome of the minor echocardiogram ab-
ormalities, we chose to further study
major” echocardiogram abnormalities.
lthough the definition of a “major
TE abnormality” can be debated, we
hose those findings we thought would
e sure to prompt treatment, work-up,
r serial follow-up. Using our defini-
ion, we found that new major TTE
bnormalities were significantly more
revalent in A compared with I studies,
uggesting that the AC for echocardi-
graphy successfully stratifies these
tudies. It is important to note, how-
ver, that echocardiogram findings
hould not be the only determinant of
hether an echocardiogram was neces-
ary or appropriate, because a normal
tudy may provide important clinical
nformation that may change patient
anagement whereas an incidental
nding unrelated to study indication
ay not.
The analysis of studies according to
rdering physician specialty reveals that
ardiac specialists are significantly less
Percent With
New TTE
Abnormalities
Percent With
New Major TTE
Abnormality
43 (n 6) 36 (n 5)
45 (n 5) 36 (n 4)
19 (n 4) 14 (n 3)
20 (n 1) 0 (n 0)
30 (n 8) 15 (n 4)
21 (n 7) 21 (n 7)
42 (n 19) 18 (n 8)
80 (n 4) 60 (n 3)
50 (n 3) 17 (n 1)r Ec
d
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s), %
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670er studies for I indications. Although
ll the reasons for this cannot be deter-
ined by our study, it should be noted
hat the AC documents are designed to
arallel evidence-based guidelines.
hus, a greater familiarity with cardio-
ascular guidelines for the use of car-
iac imaging among cardiac specialists
ight be expected and may contribute
o this discrepancy. This finding also
epresents an opportunity for targeted
ducation of ordering physicians on the
se of TTE, which may improve ap-
ropriate use and lower costs without
mpacting high-quality care.
Among the I indications, it was no-
able that indication 42 (“routine
yearly] re-evaluation of patients with
eart failure [systolic or diastolic] in
hom there is no change in clinical
tatus”), and indication 21 (“routine
yearly] re-evaluation of an asymptom-
tic patient with mild native aortic
tenosis or mild to moderate native
itral stenosis and no change in clinical
tatus”) were the only indications more
requently ordered by cardiac specialists
3). Among indication 42 studies, 29%
ere ordered as a follow-up to a previ-
us LVEF 35% to determine candi-
acy for implantable cardioverter-
efibrillator after a trial of maximal
edical therapy or coronary revascular-
zation, an indication current guidelines
ould support (9). This result high-Working Group, American Society of Echo-
4ituation not addressed, yet one for
hich reviewers thought an indication
n the AC document broadly applies. It
lso points to the challenges of clinical
pplication of the AC document and
he need for an appeals process, partic-
larly if this document becomes widely
sed for reimbursement decisions.
tudy limitations. There are limitations
f this study that deserve mention.
irst, because we evaluated the clinical
ractice of echocardiography at a single
enter university hospital, the results
ay be different in other practice types.
or example, solid-organ transplant
rograms at our institution accounted
or 43% of studies ordered for indica-
ions not addressed by the AC docu-
ents. Second, our study does not
ddress the clinical impact of echocar-
iographic findings and, thus, whether
hey change patient management,
hich is the ultimate determinant of
he true appropriateness of a diagnostic
maging study. Third, because review-
rs were not blinded to patient charac-
eristics such as gender and referring
hysician specialty, we cannot exclude
he possibility that this introduced bias
nto the process of indication determi-
ation. Finally, it should be noted that
ur study only addressed the clinical
ractice of TTE, whereas transesopha-
eal echocardiography also is covered in
he AC for echocardiography. There-ogy (erratum in J Am Coll Cardiol 2005;46:
5
6ddress the clinical application of the AC
or echocardiography on the practice of
ransesophageal echocardiography.
onclusions
he ACCF/ASE AC for Echocardi-
graphy was published in an effort to
stablish a rational approach to the use
f echocardiography in the delivery of
igh-quality care. Because these criteria
ay ultimately be used for reimburse-
ent determinations, it is critical that
hey reflect and stratify the appropriate
linical practice of echocardiography.
ur study examined the clinical appli-
ation of these criteria, and we found
hat they encompass the majority clin-
cal practice of echocardiography in our
nstitution. The application of these
riteria was found to be feasible and
eproducible, and they appear to suc-
essfully stratify test ordering according
o likelihood of finding important TTE
bnormalities. However, we also iden-
ify a number of revisions of the AC for
chocardiography that will need to be
ddressed to allow routine widespread
linical application of these criteria.
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edicine, University of Chicago Medical
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11B, MC6080, Chicago, Illinois 60637.ights an example of a specific clinical fore, further study will be needed to E-mail: pward@medicine.bsd.uchicago.edu.E F E R E N C E S
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